Nexus Past Earnings Performance

Past criteria checks 4/6

Nexus has been growing earnings at an average annual rate of 17.9%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 11.9% per year. Nexus's return on equity is 9.9%, and it has net margins of 10.1%.

Key information

17.9%

Earnings growth rate

15.7%

EPS growth rate

Healthcare Services Industry Growth7.9%
Revenue growth rate11.9%
Return on equity9.9%
Net Margin10.1%
Next Earnings Update04 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Nexus makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:NXU Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242652700
30 Jun 242612600
31 Mar 242532500
31 Dec 232452400
30 Sep 232332300
30 Jun 232242100
31 Mar 232172100
31 Dec 222121900
30 Sep 222042000
30 Jun 222001900
31 Mar 221961800
31 Dec 211911700
30 Sep 211881700
30 Jun 211791600
31 Mar 211711600
31 Dec 201661500
30 Sep 201601300
30 Jun 201591300
31 Mar 201551100
31 Dec 191511100
30 Sep 191511000
30 Jun 191451000
31 Mar 191441100
31 Dec 181411100
30 Sep 181331100
30 Jun 181301000
31 Mar 181271000
31 Dec 171241000
30 Sep 17121900
30 Jun 17119900
31 Mar 17115800
31 Dec 16112800
30 Sep 16110800
30 Jun 16108700
31 Mar 16106800
31 Dec 15103800
30 Sep 1599900
30 Jun 1594900
31 Mar 1589800
31 Dec 1485800
30 Sep 1482700
30 Jun 1481800
31 Mar 1480700
31 Dec 1378700

Quality Earnings: NXU has high quality earnings.

Growing Profit Margin: NXU's current net profit margins (10.1%) are higher than last year (10%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NXU's earnings have grown by 17.9% per year over the past 5 years.

Accelerating Growth: NXU's earnings growth over the past year (14.4%) is below its 5-year average (17.9% per year).

Earnings vs Industry: NXU earnings growth over the past year (14.4%) exceeded the Healthcare Services industry 3.6%.


Return on Equity

High ROE: NXU's Return on Equity (9.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 03:53
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nexus AG is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wolfgang SpechtBerenberg
Charlotte FriedrichsBerenberg
Martin JungfleischBNP Paribas Exane